Nicholas R Natale Selected Research

Isoxazoles

11/2020	10-N-heterocylic aryl-isoxazole-amides (AIMs) have robust anti-tumor activity against breast and brain cancer cell lines and useful fluorescence properties.
8/2009	Bis-anthracenyl isoxazolyl amides have enhanced anticancer activity.
2/2009	Design, synthesis and biological evaluation of a novel class of anticancer agents: anthracenylisoxazole lexitropsin conjugates.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nicholas R Natale Research Topics

Disease

3	Neoplasms (Cancer) 11/2020 - 02/2009
1	Glioblastoma (Glioblastoma Multiforme) 01/2022
1	Stroke (Strokes) 04/2021
1	Ischemic Stroke 04/2021
1	Ischemia 04/2021
1	Brain Neoplasms (Brain Tumor) 11/2020
1	Substance-Related Disorders (Drug Abuse) 01/2012
1	Glioma (Gliomas) 08/2009
1	Alzheimer Disease (Alzheimer's Disease) 01/2006

Drug/Important Bio-Agent (IBA)

3	IsoxazolesIBA 11/2020 - 02/2009
3	AmidesIBA 11/2020 - 02/2009
2	Glutamic Acid (Glutamate)FDA Link 01/2012 - 01/2006
1	diphenyl (biphenyl)IBA 01/2022
1	FSC 231IBA 04/2021
1	CalciumIBA 04/2021
1	AMPA Receptors (AMPA Receptor)IBA 04/2021
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2012
1	Cystine (L-Cystine)IBA 01/2012
1	Carrier Proteins (Binding Protein)IBA 01/2006
1	N-Methylaspartate (NMDA)IBA 01/2006
1	Memantine (Namenda)FDA Link 01/2006

Therapy/Procedure

1	Therapeutics 04/2021